Zeronda Tyler (CIK 1867033) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Sell VYNE (3,464 shares), Sell VYNE (4,007 shares), Sell VYNE (7,858 shares), Sell VYNE (3,420 shares), Sell VYNE (3,420 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | VYNE Therapeutics Inc. (VYNE) | CHIEF FINANCIAL OFFICER | Sell | 3,464 | $2,254 |
| 2026-04-02 | VYNE Therapeutics Inc. (VYNE) | CHIEF FINANCIAL OFFICER | Sell | 4,007 | $2,394 |
| 2026-01-05 | VYNE Therapeutics Inc. (VYNE) | CHIEF FINANCIAL OFFICER | Sell | 7,858 | $4,558 |
| 2025-10-02 | VYNE Therapeutics Inc. (VYNE) | CHIEF FINANCIAL OFFICER | Sell | 3,420 | $1,163 |
| 2025-07-02 | VYNE Therapeutics Inc. (VYNE) | CHIEF FINANCIAL OFFICER | Sell | 3,420 | $5,643 |
| 2025-04-02 | VYNE Therapeutics Inc. (VYNE) | CHIEF FINANCIAL OFFICER | Sell | 8,399 | $13,270 |
Source: SEC Form 4 filings · as of 2026-07-02